Results

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	RMSD	Seq. Identity (%)	HETATM
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	1q2w	3C-LIKE PROTEASE (SARSr-CoV)	5 / 12	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.57A	20.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	1q2w	3C-LIKE PROTEASE (SARSr-CoV)	5 / 11	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.49A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	1q2w	3C-LIKE PROTEASE (SARSr-CoV)	5 / 10	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.56A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	1uk2	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP A 176 GLY A 149 SER A 147 PHE A 112 HIS A 163	1.41A	20.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	1wof	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLY A 138 GLY B 2 SER B 1 PHE B 291 PHE B 3	1.64A	19.31	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	1z1j	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP A 153 GLY B1124 GLU B1014 SER B1010 PHE A 150	1.69A	20.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	1z1j	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLY B1138 GLY A 2 SER A 1 PHE A 291 PHE A 3	1.62A	21.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	1z1j	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP A 153 GLY B1124 GLU B1014 SER B1010 PHE A 150	1.61A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	2a5k	3C-LIKE PEPTIDASE (SARSr-CoV)	5 / 12	GLY B 2 GLY A 138 TYR A 126 GLU A 166 TYR A 118	1.72A	21.85	None None None AZP A 307 (-3.5A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	2a5k	3C-LIKE PEPTIDASE (SARSr-CoV)	5 / 11	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.67A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	2acf	REPLICASE POLYPROTEIN 1AB (SARS-COV Tor2)	5 / 12	ASP D 287 GLY D 261 GLY D 260 GLY D 279 PHE D 314	1.61A	15.83	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	2ajf	ACE2 SPIKE PROTEIN (Homo sapiens; SARSr-CoV)	4 / 7	TRP A 349 GLN A 42 TYR E 484 TYR A 41	1.50A	16.86	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	2ajf	SPIKE PROTEIN (SARSr-CoV)	5 / 12	ASP F 414 GLY F 418 SER F 500 PHE F 416 PHE F 451	1.73A	13.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	2amd	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP A 176 GLY A 149 SER A 147 PHE A 112 HIS A 163	1.58A	20.00	None None None None 9IN A1001 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	2amd	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP A 176 GLY A 149 SER A 147 PHE A 112 HIS A 163	1.60A	20.00	None None None None 9IN A1001 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	2amd	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP A 176 GLY A 149 SER A 147 PHE A 112 HIS A 163	1.55A	20.00	None None None None 9IN A1001 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	2amq	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.57A	20.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	2amq	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 10	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.55A	20.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	2cjr	NUCLEOCAPSID PROTEIN (SARS-COV TW1)	5 / 12	GLY F 285 GLY E 317 SER E 319 PHE E 315 PHE E 316	1.68A	12.50	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	2fav	REPLICASE POLYPROTEIN 1AB (PP1AB) (ORF1AB) (SARSr-CoV)	5 / 12	ASP A 106 GLY A 80 GLY A 79 GLY A 98 PHE A 133	1.71A	15.47	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	2fav	REPLICASE POLYPROTEIN 1AB (PP1AB) (ORF1AB) (SARSr-CoV)	5 / 12	ASP B 106 GLY B 80 GLY B 79 GLY B 98 PHE B 133	1.61A	15.13	None None None None APR B 477 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	2fe8	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	4 / 7	GLN B 134 TYR B 137 TYR B 155 ILE B 152	1.70A	22.08	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	2fe8	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	5 / 11	ASP A 23 GLY A 29 GLY A 33 GLU B 71 SER B 67	1.19A	20.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	2fe8	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	5 / 12	ASP A 23 GLY A 29 GLY A 33 GLU B 71 SER B 67	1.38A	20.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	2ga6	ORF1A POLYPROTEIN (SARSr-CoV)	5 / 12	GLY P 34 GLY P 35 SER P 33 PHE P 16 TYR P 27	1.31A	13.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	2ga6	ORF1A POLYPROTEIN (SARSr-CoV)	5 / 12	ASP G 106 GLY G 34 GLY G 35 SER G 33 PHE G 16	1.52A	13.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	2ga6	ORF1A POLYPROTEIN (SARSr-CoV)	5 / 12	GLY P 34 GLY P 35 SER P 33 PHE P 16 TYR P 27	1.30A	13.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	2ga6	ORF1A POLYPROTEIN (SARSr-CoV)	5 / 12	ASP U 106 GLY U 34 GLY U 35 SER U 33 PHE U 16	1.61A	13.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	2op9	REPLICASE POLYPROTEIN 1AB (PP1AB, ORF1AB) 3C-LIKE PROTEINASE (3CL-PRO, 3CLP) (SARSr-CoV)	5 / 10	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.68A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	2op9	REPLICASE POLYPROTEIN 1AB (PP1AB, ORF1AB) 3C-LIKE PROTEINASE (3CL-PRO, 3CLP) (SARSr-CoV)	5 / 11	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.69A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	2op9	REPLICASE POLYPROTEIN 1AB (PP1AB, ORF1AB) 3C-LIKE PROTEINASE (3CL-PRO, 3CLP) (SARSr-CoV)	5 / 12	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.71A	19.78	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	2op9	REPLICASE POLYPROTEIN 1AB (PP1AB, ORF1AB) 3C-LIKE PROTEINASE (3CL-PRO, 3CLP) (SARSr-CoV)	5 / 12	GLY A 2 GLY B 138 TYR B 126 SER A 1 TYR B 118	1.57A	22.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	2q6g	REPLICASE POLYPROTEIN 1AB (SARS-COV BJ01)	5 / 11	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.66A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	2qc2	3C-LIKE PROTEINASE (-)	5 / 12	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.49A	20.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	2qc2	3C-LIKE PROTEINASE (-)	5 / 10	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.47A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	2qc2	3C-LIKE PROTEINASE (-)	5 / 11	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.42A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	2vj1	MAIN PROTEINASE (SARSr-CoV)	5 / 11	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.68A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	2vj1	MAIN PROTEINASE (SARSr-CoV)	5 / 10	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.67A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	2vj1	MAIN PROTEINASE (SARSr-CoV)	5 / 12	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.70A	19.78	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	2xyq	NSP10 (SARSr-CoV)	5 / 12	ASP B 106 GLY B 34 GLY B 35 SER B 33 PHE B 16	1.40A	12.80	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	2xyq	NSP10 (SARSr-CoV)	5 / 12	GLY B 34 GLY B 35 SER B 33 PHE B 16 TYR B 27	1.13A	12.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	2xyq	NSP10 (SARSr-CoV)	5 / 12	GLY B 34 GLY B 35 SER B 33 PHE B 16 TYR B 27	1.13A	12.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	2xyq	NSP10 (SARSr-CoV)	5 / 12	ASP B 106 GLY B 34 GLY B 35 SER B 33 PHE B 16	1.37A	12.17	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	2xyv	NSP10 (SARSr-CoV)	5 / 12	ASP B 106 GLY B 34 GLY B 35 SER B 33 PHE B 16	1.39A	12.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	2xyv	NSP10 (SARSr-CoV)	5 / 12	GLY B 34 GLY B 35 SER B 33 PHE B 16 TYR B 27	1.12A	12.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	2xyv	NSP10 (SARSr-CoV)	5 / 12	GLY B 34 GLY B 35 SER B 33 PHE B 16 TYR B 27	1.12A	12.36	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	2xyv	NSP10 (SARSr-CoV)	5 / 12	ASP B 106 GLY B 34 GLY B 35 SER B 33 PHE B 16	1.42A	13.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	2z9l	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLY A 2 GLY B 138 TYR B 126 SER A 1 TYR B 118	1.46A	21.85	None None None DMS B 603 ( 4.3A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	3aw1	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.59A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	3aw1	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.58A	20.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	3aw1	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 10	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.54A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3bgf	F26G19 FAB SPIKE PROTEIN S1 (Mus musculus; SARSr-CoV)	4 / 7	TYR S 491 GLN S 492 TYR L 94 ILE L 29	1.68A	19.83	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3bgf	F26G19 FAB (Mus musculus)	4 / 7	TYR L 94 GLN L 90 TYR L 91 ILE H 97	1.59A	23.29	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	3bgf	F26G19 FAB SPIKE PROTEIN S1 (Mus musculus; SARSr-CoV)	5 / 12	ASP B 56 GLY A 490 GLY A 391 TYR A 494 PHE A 483	1.77A	18.47	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	3bgf	F26G19 FAB SPIKE PROTEIN S1 (Mus musculus; SARSr-CoV)	5 / 12	TRP C 96 GLY A 488 GLY A 490 TYR A 491 TYR C 91	1.71A	18.35	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	3bgf	F26G19 FAB SPIKE PROTEIN S1 (Mus musculus; SARSr-CoV)	5 / 12	ASP B 56 GLY A 490 GLY A 391 TYR A 494 PHE A 483	1.80A	18.47	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3d0g	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	TYR E 494 GLN E 492 TYR E 491 ILE E 405	1.69A	20.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	3d0g	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ASP F 414 GLY F 418 SER F 500 PHE F 416 PHE F 451	1.69A	14.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3d0h	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	4 / 7	TYR A 521 TYR A 217 TYR A 516 ILE A 513	1.55A	16.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3d0h	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	TYR E 494 GLN E 492 TYR E 491 ILE E 405	1.69A	20.44	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	3d0h	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	GLY E 490 GLY E 488 GLY A 354 SER E 487 PHE A 356	1.62A	15.16	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	3d0h	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 10	ASP B 225 GLY B 575 TYR B 521 GLU B 571 PHE B 400	1.63A	22.65	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	3d0h	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	ASP F 393 GLY F 488 GLY B 354 SER F 487 PHE F 483	1.74A	14.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	3d0i	ACE2 SPIKE GLYCOPROTEIN (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	ASP E 393 GLY E 488 GLY A 354 SER E 487 PHE E 483	1.76A	14.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	3d0i	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 12	ASP A 350 GLY A 395 GLY A 561 TYR A 385 PHE A 390	1.76A	22.65	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	3d62	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLY A 138 TYR A 126 SER A 139 TYR A 161 PHE A 112	1.66A	22.06	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	3e91	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.60A	19.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	3e91	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.59A	19.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	3e91	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 10	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.56A	19.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	3e91	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLY B 138 GLY A 2 SER A 1 PHE A 291 PHE A 3	1.57A	21.88	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	3f9g	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.67A	19.78	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	3f9g	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.64A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	3f9h	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.65A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	3f9h	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLY B 283 GLY B 2 PHE B 291 PHE B 3 TYR A 126	1.73A	21.79	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	3f9h	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.68A	20.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_D_GNTD301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3i6g	HLA, A-2 (Homo sapiens)	5 / 10	TYR A 7 TYR A 59 THR A 163 TYR A 159 GLN D 155	1.57A	20.85	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	3i6g	HLA, A-2 MEMBRANE PROTEIN (Homo sapiens)	5 / 10	TRP C 3 GLY C 0 TYR A 99 GLU A 63 PHE A 9	1.76A	2.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3i6k	HLA, A-2 (Homo sapiens)	4 / 7	TYR A 118 TYR A 84 TYR A 116 ILE A 124	1.41A	20.85	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	3iwm	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLY B 2 GLY A 138 TYR A 126 SER B 1 TYR A 118	1.68A	21.85	None None None PJE H 5 ( 4.7A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	3m3s	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.63A	20.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	3m3s	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.56A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	3m3s	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 10	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.56A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	3m3v	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP B 187 GLY B 143 GLY B 146 SER B 144 HIS B 172	1.68A	19.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	3m3v	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.54A	19.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	3m3v	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.55A	19.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	3m3v	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	ASP B 187 GLY B 143 GLY B 146 SER B 144 HIS B 172	1.69A	19.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	3m3v	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 10	ASP B 153 GLY A 124 GLU A 14 SER A 10 PHE B 150	1.51A	19.68	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	3r24	NSP10 AND NSP11 (SARSr-CoV)	5 / 12	GLY B 34 GLY B 35 SER B 33 PHE B 16 TYR B 27	1.28A	14.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	3r24	NSP10 AND NSP11 (SARSr-CoV)	5 / 10	ASP B 106 GLY B 34 GLY B 35 SER B 33 PHE B 16	1.80A	13.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	3r24	NSP10 AND NSP11 (SARSr-CoV)	5 / 12	GLY B 34 GLY B 35 SER B 33 PHE B 16 TYR B 27	1.27A	14.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	3r24	NSP10 AND NSP11 (SARSr-CoV)	5 / 12	ASP B 106 GLY B 34 GLY B 35 SER B 33 PHE B 16	1.73A	13.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	3r24	NSP10 AND NSP11 (SARSr-CoV)	5 / 12	ASP B 106 GLY B 34 GLY B 35 SER B 33 PHE B 16	1.49A	13.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	3r24	NSP10 AND NSP11 (SARSr-CoV)	5 / 12	ASP B 106 GLY B 34 GLY B 35 SER B 33 PHE B 16	1.45A	13.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3scj	ACE2 SPIKE GLYCOPROTEIN (Homo sapiens; SARSr-CoV)	4 / 7	TRP B 349 GLN B 42 TYR F 484 TYR B 41	1.39A	16.75	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	3scj	ACE2 (Homo sapiens)	5 / 12	ASP B 350 GLY B 395 GLY B 561 TYR B 385 PHE B 390	1.73A	23.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	3sck	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ASP F 414 GLY F 418 SER F 500 PHE F 416 PHE F 451	1.60A	14.51	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	3sck	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	4 / 7	TYR B 521 TYR B 217 TYR B 516 ILE B 513	1.55A	15.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	3sck	ACE2 (Paguma larvata; Homo sapiens; SARSr-CoV)	5 / 10	ASP B 225 GLY B 575 TYR B 521 GLU B 571 PHE B 400	1.67A	23.27	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	3snd	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 10	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.56A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	3vb6	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.52A	19.93	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	4hi3	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.68A	19.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	4m0w	REPLICASE POLYPROTEIN 1A UBIQUITIN (Bos taurus; SARSr-CoV)	5 / 12	ASP A 303 GLY B 76 GLY B 75 GLY A 272 TYR A 265	1.67A	21.31	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	4m0w	REPLICASE POLYPROTEIN 1A (SARSr-CoV)	4 / 7	GLN A 238 TYR A 214 TYR A 311 ILE A 315	1.52A	22.08	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	4mm3	PAPAIN-LIKE PROTEINASE (SARSr-CoV)	4 / 7	GLN B 238 TYR B 214 TYR B 311 ILE B 315	1.51A	22.08	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 10	ASP A 164 GLY A 248 TYR A 279 SER A 247 HIS A 171	1.48A	19.37	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	4rna	PAPAIN-LIKE PROTEASE (Human betacoronavirus 2c EMC/2012)	5 / 12	ASP A 164 GLY A 248 TYR A 279 SER A 247 HIS A 171	1.50A	19.37	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	5b6o	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 11	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.71A	20.70	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	5b6o	3C-LIKE PROTEINASE (SARSr-CoV)	5 / 12	GLY A 2 GLY B 138 TYR B 126 SER A 1 TYR B 118	1.67A	20.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	5c8s	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	GLY D 416 GLY D 417 GLY D 413 SER D 418 HIS D 264	1.64A	21.65	None None None None ZN D 602 (-2.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	5c8s	GUANINE-N7 METHYLTRANSFERASE NSP10 (SARSr-CoV)	5 / 12	ASP D 41 GLY C 70 GLY C 69 SER C 72 PHE D 33	1.69A	21.88	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	5c8s	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	TRP D 385 TYR D 392 SER D 507 PHE D 431 PHE D 436	1.76A	21.65	G3A D 606 ( 4.3A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	5c8t	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	TRP D 385 TYR D 392 SER D 507 PHE D 431 PHE D 436	1.70A	21.84	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	5c8t	GUANINE-N7 METHYLTRANSFERASE (SARSr-CoV)	5 / 12	TRP D 385 TYR D 392 SER D 507 PHE D 431 PHE D 436	1.67A	21.25	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	5c8u	NSP10 (SARSr-CoV)	5 / 12	ASP A 106 GLY A 34 GLY A 35 SER A 33 PHE A 16	1.30A	13.71	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	5c8u	NSP10 (SARSr-CoV)	5 / 12	GLY A 34 GLY A 35 SER A 33 PHE A 16 TYR A 27	1.17A	14.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	5c8u	NSP10 (SARSr-CoV)	5 / 12	GLY A 34 GLY A 35 SER A 33 PHE A 16 TYR A 27	1.19A	14.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	5c8u	NSP10 (SARSr-CoV)	5 / 12	ASP A 106 GLY A 34 GLY A 35 SER A 33 PHE A 16	1.28A	12.90	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	5e6j	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	4 / 7	GLN A 238 TYR A 214 TYR A 311 ILE A 315	1.59A	22.08	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	ASP O 106 GLY O 34 GLY O 35 SER O 33 PHE O 16	1.34A	11.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	GLY O 34 GLY O 35 SER O 33 PHE O 16 TYR O 27	1.15A	11.76	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	TRP B 385 TYR B 392 SER B 507 PHE B 431 PHE B 436	1.73A	21.02	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	ASP O 106 GLY O 34 GLY O 35 SER O 33 PHE O 16	1.36A	12.60	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	GLY O 34 GLY O 35 SER O 33 PHE O 16 TYR O 27	1.16A	11.76	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	5nfy	POLYPROTEIN 1AB (SARS-COV Frankfurt 1)	5 / 12	TRP B 385 TYR B 392 SER B 507 PHE B 431 PHE B 436	1.76A	21.95	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	5tl6	REPLICASE POLYPROTEIN 1AB (SARSr-CoV)	4 / 7	GLN D 238 TYR D 214 TYR D 311 ILE D 315	1.53A	21.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	5tl7	REPLICASE POLYPROTEIN 1AB UBIQUITIN-LIKE PROTEIN ISG15 (Mus musculus; SARSr-CoV)	5 / 12	ASP D 109 GLY D 272 GLY C 154 GLY D 164 TYR D 113	1.31A	21.42	None AYE C 155 ( 4.7A) AYE C 155 (-2.3A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	5x4s	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ASP A 24 GLY A 246 SER A 239 PHE A 137 PHE A 76	1.48A	20.41	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	5x4s	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	ASP A 24 GLY A 246 SER A 239 PHE A 137 PHE A 76	1.52A	20.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	5x59	S PROTEIN (MERS-CoV)	4 / 7	TYR C 58 GLN B 628 TYR C 71 ILE C 69	1.37A	9.91	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	GLY B 780 GLY B 781 PHE B1034 PHE B 909 PHE B 784	1.59A	17.12	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	GLY A 781 GLY A 780 TYR C 689 PHE A 880 TYR A 899	1.68A	17.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	5x5b	SPIKE GLYCOPROTEIN (SARS-COV BJ01)	5 / 12	GLY B 780 GLY B 781 PHE B1034 PHE B 909 PHE B 784	1.59A	17.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	5x5c	S PROTEIN (MERS-CoV)	5 / 12	GLY A 552 GLY A 551 GLY A 550 SER A 546 SER A 508	1.27A	18.00	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	5y3e	REPLICASE POLYPROTEIN 1A (SARSr-CoV)	4 / 7	GLN A 238 TYR A 214 TYR A 311 ILE A 315	1.53A	22.08	None None NA A 402 (-4.8A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLY B 780 GLY B 781 PHE B1034 PHE B 909 PHE B 784	1.47A	17.45	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLY C 255 GLY C 86 PHE C 103 PHE C 83 PHE C 231	1.74A	18.20	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6acj	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLY B 780 GLY B 781 PHE B1034 PHE B 909 PHE B 784	1.46A	17.38	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6ack	ACE2 (Homo sapiens)	5 / 12	ASP D 225 GLY D 575 TYR D 521 GLU D 571 PHE D 400	1.37A	23.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	6ack	ACE2 (Homo sapiens)	5 / 10	ASP D 225 GLY D 575 TYR D 521 GLU D 571 PHE D 400	1.28A	23.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6crv	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	4 / 7	TRP C1084 GLN A 895 TYR A 899 ILE C1115	1.73A	11.65	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6crw	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	ASP B 727 GLY A 536 PHE A 527 PHE B 837 PHE A 558	1.74A	17.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	6crz	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	GLY A 780 GLY A 781 TYR A 778 PHE A 784 TYR C 689	1.56A	18.02	None None NAG A1314 (-4.7A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6cs0	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	5 / 12	GLY A 780 GLY A 781 TYR A 778 PHE A 784 TYR C 689	1.55A	18.02	None None NAG A1314 (-4.7A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	6cs2	ACE2 (Homo sapiens)	5 / 11	ASP D 292 GLY D 422 SER D 420 PHE D 369 HIS D 417	1.48A	23.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6cs2	ACE2 (Homo sapiens)	5 / 12	ASP D 292 GLY D 422 SER D 420 PHE D 369 HIS D 417	1.51A	23.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6cs2	ACE2 (Homo sapiens)	4 / 7	TYR D 521 TYR D 217 TYR D 516 ILE D 513	1.68A	16.75	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	6cs2	ACE2 SPIKE GLYCOPROTEIN,FIBRITI N (Homo sapiens; SARSr-CoV)	5 / 12	GLY D 354 GLY B 488 GLU D 37 PHE B 483 TYR B 484	1.63A	21.98	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	6cs2	ACE2 (Homo sapiens)	5 / 10	ASP D 295 GLY D 422 SER D 420 PHE D 369 HIS D 417	1.75A	23.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6cs2	SPIKE GLYCOPROTEIN,FIBRITI N (SARSr-CoV)	4 / 7	TRP C1084 GLN A 895 TYR A 899 ILE C1115	1.46A	11.65	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6cs2	ACE2 (Homo sapiens)	5 / 12	ASP D 292 GLY D 422 SER D 420 PHE D 369 HIS D 417	1.52A	23.30	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6cs2	ACE2 (Homo sapiens)	5 / 12	ASP D 292 GLY D 422 SER D 420 PHE D 369 HIS D 417	1.50A	23.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	6jyt	HELICASE (SARSr-CoV)	5 / 12	GLY B 67 GLY B 66 PHE B 90 PHE B 81 TYR B 48	1.55A	22.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6jyt	HELICASE (SARSr-CoV)	5 / 12	GLY B 67 GLY B 66 PHE B 90 PHE B 81 TYR B 48	1.55A	22.07	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6jyt	HELICASE (SARSr-CoV)	4 / 7	GLN B 270 TYR B 298 TYR B 269 ILE B 304	1.61A	17.39	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6jyt	HELICASE (SARSr-CoV)	5 / 12	GLY A 67 GLY A 66 TYR A 70 PHE A 81 PHE A 90	1.80A	20.96	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6m17	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	GLY C 66 GLY C 67 GLY C 68 TYR C 322 PHE C 58	1.59A	22.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6m17	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	GLY C 66 GLY C 67 GLY C 68 TYR C 322 PHE C 58	1.58A	22.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	6m17	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 11	GLY A 67 GLY A 68 TYR A 322 GLU A 261 HIS A 65	1.67A	22.24	None None None NAG A 703 (-2.6A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	6m17	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	TRP A 176 GLY A 397 PHE A 420 TYR A 139 PHE A 421	1.63A	22.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6m18	ACE2 (Homo sapiens)	4 / 7	TYR B 521 TYR B 217 TYR B 516 ILE B 513	1.61A	14.32	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6m18	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	ASP C 173 TRP C 176 GLY C 395 GLY C 397 PHE C 420	1.68A	21.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6m18	SODIUM-DEPENDENT NEUTRAL AMINO ACID TRANSPORTER B(0)AT1 (Homo sapiens)	5 / 12	GLY C 66 GLY C 67 GLY C 68 PHE C 255 PHE C 58	1.63A	22.52	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	6m1d	ACE2 (Homo sapiens)	5 / 11	GLY B 561 GLY B 395 TYR B 381 GLU B 564 PHE B 400	1.65A	20.94	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6m1d	ACE2 (Homo sapiens)	5 / 12	GLY B 561 GLY B 395 TYR B 381 GLU B 564 PHE B 400	1.66A	20.59	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	6m1d	ACE2 (Homo sapiens)	5 / 12	GLY B 561 GLY B 395 TYR B 381 GLU B 564 PHE B 400	1.68A	20.24	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 11	ASP C 153 GLY A 124 GLU A 14 SER A 10 PHE C 150	1.66A	18.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	GLY C 2 GLY A 138 TYR A 126 SER C 1 TYR A 118	1.65A	19.85	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	ASP C 153 GLY A 124 GLU A 14 SER A 10 PHE C 150	1.68A	18.98	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6m2n	3CL PROTEASE (SARS-CoV-2)	5 / 12	GLY D 2 GLY B 138 TYR B 126 SER D 1 TYR B 118	1.60A	19.85	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6m71	NSP12 (SARS-CoV-2)	5 / 12	ASP A 833 GLY A 841 GLY A 839 PHE A 428 PHE A 429	1.74A	19.48	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6m71	NSP8 (SARS-CoV-2)	4 / 7	TRP B 182 GLN B 168 TYR B 138 ILE B 132	1.79A	20.87	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6m71	NSP12 (SARS-CoV-2)	5 / 12	ASP A 833 GLY A 841 GLY A 839 PHE A 428 PHE A 429	1.78A	19.47	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6nb6	SPIKE GLYCOPROTEIN (SARSr-CoV)	4 / 7	GLN A 883 TYR A 886 TYR B1029 ILE B 891	1.48A	10.96	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6nb7	SPIKE GLYCOPROTEIN (SARSr-CoV)	5 / 12	GLY C 780 GLY C 781 TYR C 778 PHE C 909 PHE C 784	1.78A	17.89	None None NAG C1328 (-4.6A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	6nur	NSP12 (SARSr-CoV)	5 / 10	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.75A	19.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6nur	NSP12 (SARSr-CoV)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.53A	19.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6nur	NSP12 (SARSr-CoV)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.53A	19.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6nur	NSP12 (SARSr-CoV)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.49A	19.02	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6vsb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	5 / 12	ASP A 574 GLY A 548 GLY A 550 PHE A 592 PHE B 855	1.76A	17.69	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6vsb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 7	TYR C 495 GLN C 506 TYR C 508 ILE C 418	1.62A	10.73	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6vw1	ACE2 (Homo sapiens)	5 / 12	ASP B 350 GLY B 395 GLY B 561 TYR B 385 PHE B 390	1.74A	22.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6vyb	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 7	GLN C 901 TYR C 904 TYR B1047 ILE B 909	1.73A	11.41	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6w02	NSP3 (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.62A	13.78	None None None None APR A 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6w02	NSP3 (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.63A	14.18	None None None None APR A 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6w02	NSP3 (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.64A	14.18	None None None None APR A 201 (-3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6w41	CR3022 FAB HEAVY CHAIN CR3022 FAB LIGHT CHAIN (Homo sapiens)	4 / 7	TRP H 47 TYR L 27 TYR L 91 ILE H 50	1.64A	22.03	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6w41	CR3022 FAB HEAVY CHAIN CR3022 FAB LIGHT CHAIN SPIKE PROTEIN S1 (Homo sapiens; SARS-CoV-2)	5 / 12	GLY H 97 GLY C 381 TYR L 32 SER H 99 PHE C 515	1.79A	14.55	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6w6y	NSP3 (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.72A		None None None None AMP A 201 ( 4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6w6y	NSP3 (SARS-CoV-2)	5 / 12	ASP B 105 GLY B 79 GLY B 78 GLY B 97 PHE B 132	1.58A		None None None None MES B 201 ( 3.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	4 / 7	GLN C 237 TYR C 213 TYR C 310 ILE C 314	1.58A	23.01	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	4 / 7	GLN A 237 TYR A 213 TYR A 310 ILE A 314	1.62A	23.01	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6w9c	PAPAIN-LIKE PROTEINASE (SARS-CoV-2)	4 / 7	GLN B 237 TYR B 213 TYR B 310 ILE B 314	1.45A	23.01	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6wcf	NSP3 (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.65A		None None None None MES A 201 (-2.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6wcf	NSP3 (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.63A	13.78	None None None None MES A 201 (-2.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6wcf	NSP3 (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.64A	14.18	None None None None MES A 201 (-2.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6wen	NSP3 (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.69A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6wey	NSP3 (SARS-CoV-2)	5 / 12	GLY A 283 GLY A 282 GLY A 301 SER A 315 PHE A 336	1.52A	13.89	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6wey	NSP3 (SARS-CoV-2)	5 / 12	ASP A 309 GLY A 283 GLY A 282 GLY A 301 PHE A 336	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6wji	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	5 / 12	GLY E 284 GLY F 316 PHE F 315 TYR E 333 PHE F 314	1.75A	11.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6wji	NUCLEOCAPSID PROTEIN (SARS-CoV-2)	5 / 12	GLY D 284 GLY C 316 PHE C 315 TYR D 333 PHE C 314	1.78A	11.21	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.66A	17.66	None None None None APR A 201 (-3.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	ASP D 105 GLY D 79 GLY D 78 GLY D 97 PHE D 132	1.63A		None None None None APR D 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.67A		None None None None APR A 201 (-3.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	ASP C 105 GLY C 79 GLY C 78 GLY C 97 PHE C 132	1.57A		None None None None APR C 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	ASP D 105 GLY D 79 GLY D 78 GLY D 97 PHE D 132	1.62A	17.66	None None None None APR D 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	ASP D 105 GLY D 79 GLY D 78 GLY D 97 PHE D 132	1.63A	17.66	None None None None APR D 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	ASP C 105 GLY C 79 GLY C 78 GLY C 97 PHE C 132	1.66A	17.66	None None None None APR C 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	ASP B 105 GLY B 79 GLY B 78 GLY B 97 PHE B 132	1.64A	17.66	None None None None APR B 201 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6woj	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.65A	17.66	None None None None APR A 201 (-3.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6wrh	PEPTIDASE C16 (SARS-CoV-2)	4 / 7	GLN A 237 TYR A 213 TYR A 310 ILE A 314	1.56A	22.80	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6wrh	PEPTIDASE C16 (SARS-CoV-2)	4 / 7	GLN A 133 TYR A 136 TYR A 154 ILE A 151	1.73A	22.80	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6xhn	3C-LIKE PROTEINASE (SARSr)	4 / 7	TRP B 207 GLN B 256 TYR B 209 ILE B 281	1.25A	20.33	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	6y2g	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 11	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.66A	18.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6y2g	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 12	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.63A	18.98	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	6y2g	REPLICASE POLYPROTEIN 1AB (SARS-CoV-2)	5 / 10	ASP A 153 GLY B 124 GLU B 14 SER B 10 PHE A 150	1.61A	18.77	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6yla	HEAVY CHAIN LIGHT CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY B 101 GLY A 381 TYR C 38 PHE A 515 PHE A 392	1.51A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yla	LIGHT CHAIN (Homo sapiens)	4 / 7	TYR L 97 TRP L 56 TYR L 98 ILE L 34	1.77A	24.03	None DMS L1601 (-3.8A) None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6yla	HEAVY CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY B 101 GLY A 381 PHE A 429 PHE A 392 PHE A 515	1.78A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	6yla	HEAVY CHAIN LIGHT CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY B 101 GLY A 381 TYR C 38 PHE A 515 PHE A 392	1.45A	18.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6yla	HEAVY CHAIN LIGHT CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY B 101 GLY A 381 TYR C 38 PHE A 515 PHE A 392	1.48A	18.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yla	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 7	TYR E 508 GLN E 506 TYR E 505 ILE E 418	1.76A	20.49	DMS E 902 (-4.0A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	4 / 7	TYR C 97 TYR C 31 TYR C 102 ILE B 102	1.66A	24.03	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	4 / 7	TRP H 47 TYR L 31 TYR L 97 ILE H 50	1.66A	22.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yla	LIGHT CHAIN (Homo sapiens)	4 / 7	TYR C 97 TRP C 56 TYR C 98 ILE C 34	1.74A	24.03	None DMS A 905 (-4.1A) DMS C 303 (-3.8A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6yla	HEAVY CHAIN LIGHT CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY B 101 GLY A 381 TYR C 38 PHE A 515 PHE A 392	1.50A	18.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	4 / 7	TRP H 47 GLN L 27 TYR L 98 ILE H 50	1.73A	22.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yla	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	4 / 7	TRP B 47 GLN C 27 TYR C 98 ILE B 50	1.74A	22.22	None None DMS C 303 (-3.8A) None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yla	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 7	TYR A 508 GLN A 506 TYR A 505 ILE A 418	1.57A	20.49	DMS A 903 (-3.5A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6ym0	HEAVY CHAIN LIGHT CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY H 101 GLY E 381 TYR L 38 PHE E 515 PHE E 392	1.63A	18.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6ym0	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 7	TYR E 508 GLN E 506 TYR E 505 ILE E 418	1.55A	20.49	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	6ym0	HEAVY CHAIN LIGHT CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY H 101 GLY E 381 TYR L 38 PHE E 515 PHE E 392	1.60A	18.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6ym0	HEAVY CHAIN LIGHT CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY H 101 GLY E 381 TYR L 38 PHE E 515 PHE E 392	1.65A	18.15	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6ym0	HEAVY CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY H 101 GLY E 381 PHE E 429 PHE E 392 PHE E 515	1.72A	18.13	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ym0	HEAVY CHAIN LIGHT CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY H 101 GLY E 381 TYR L 38 PHE E 515 PHE E 392	1.64A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6ym0	LIGHT CHAIN (Homo sapiens)	4 / 7	TYR L 97 TRP L 56 TYR L 98 ILE L 34	1.77A	24.03	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6ym0	HEAVY CHAIN LIGHT CHAIN (Homo sapiens)	4 / 7	TRP H 47 GLN L 27 TYR L 98 ILE H 50	1.73A	21.64	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ym0	HEAVY CHAIN SPIKE GLYCOPROTEIN (Homo sapiens; SARS-CoV-2)	5 / 12	GLY H 101 GLY E 381 PHE E 429 PHE E 392 PHE E 515	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yor	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 7	TYR E 508 GLN E 506 TYR E 505 ILE E 418	1.76A	20.17	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	4 / 7	TRP H 47 GLN L 27 TYR L 98 ILE H 50	1.73A	22.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yor	IGG L CHAIN (Homo sapiens)	4 / 7	TYR C 97 TRP C 56 TYR C 98 ILE C 34	1.77A	24.03	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	TRP B 109 GLY B 35 GLY B 98 TYR B 32 PHE B 29	1.80A	18.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	6yor	IGG H CHAIN (Homo sapiens)	5 / 12	TRP H 109 GLY H 35 GLY H 98 TYR H 32 PHE H 29	1.80A	18.05	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	4 / 7	TRP B 47 TYR C 31 TYR C 97 ILE B 50	1.65A	22.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yor	SPIKE GLYCOPROTEIN (SARS-CoV-2)	4 / 7	TYR A 508 GLN A 506 TYR A 505 ILE A 418	1.77A	20.17	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	4 / 7	TRP H 47 TYR L 31 TYR L 97 ILE H 50	1.66A	22.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yor	IGG H CHAIN IGG L CHAIN (Homo sapiens)	4 / 7	TRP B 47 GLN C 27 TYR C 98 ILE B 50	1.73A	22.22	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PH9_A_GNTA301_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	6yor	IGG L CHAIN (Homo sapiens)	4 / 7	TYR L 97 TRP L 56 TYR L 98 ILE L 34	1.77A	24.03	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.58A		None None None EDO A 202 ( 4.9A) EDO A 202 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP B 105 GLY B 79 GLY B 78 GLY B 97 PHE B 132	1.66A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP E 105 GLY E 79 GLY E 78 GLY E 97 PHE E 132	1.57A		None EPE E 203 (-3.3A) None None EPE E 202 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP D 105 GLY D 79 GLY D 78 GLY D 97 PHE D 132	1.62A		None None None None EDO D 205 ( 3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP C 105 GLY C 79 GLY C 78 GLY C 97 PHE C 132	1.69A		None EPE C 202 (-3.4A) None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6ywk	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP E 105 GLY E 79 GLY E 78 GLY E 97 PHE E 132	1.66A	16.99	None EPE E 203 (-3.3A) None None EPE E 202 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.57A		None None None None APR A 201 (-3.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP E 105 GLY E 79 GLY E 78 GLY E 97 PHE E 132	1.59A		None None None None APR E 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP D 105 GLY D 79 GLY D 78 GLY D 97 PHE D 132	1.61A		EDO A 206 ( 4.6A) EDO D 203 (-3.1A) None None APR D 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP B 105 GLY B 79 GLY B 78 GLY B 97 PHE B 132	1.59A		None None None None APR B 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP D 105 GLY D 79 GLY D 78 GLY D 97 PHE D 132	1.69A	16.99	EDO A 206 ( 4.6A) EDO D 203 (-3.1A) None None APR D 201 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP E 105 GLY E 79 GLY E 78 GLY E 97 PHE E 132	1.68A	16.99	None None None None APR E 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywl	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP C 105 GLY C 79 GLY C 78 GLY C 97 PHE C 132	1.60A		None None None None APR C 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP C 105 GLY C 79 GLY C 78 GLY C 97 PHE C 132	1.64A	16.99	None None None None MES C 201 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP B 105 GLY B 79 GLY B 78 GLY B 97 PHE B 132	1.68A	16.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP C 105 GLY C 79 GLY C 78 GLY C 97 PHE C 132	1.64A	16.99	None None None None MES C 201 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP B 105 GLY B 79 GLY B 78 GLY B 97 PHE B 132	1.67A	16.99	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.57A		None EDO A 204 (-3.6A) None None MES A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP B 105 GLY B 79 GLY B 78 GLY B 97 PHE B 132	1.68A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.65A	16.99	None EDO A 204 (-3.6A) None None MES A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP C 105 GLY C 79 GLY C 78 GLY C 97 PHE C 132	1.59A		None None None None MES C 201 (-3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	6ywm	NSP3 MACRODOMAIN (SARS-CoV-2)	5 / 12	ASP A 105 GLY A 79 GLY A 78 GLY A 97 PHE A 132	1.65A	16.99	None EDO A 204 (-3.6A) None None MES A 201 (-3.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	7btf	NSP12 (SARS-CoV-2)	5 / 12	ASP A 833 GLY A 841 GLY A 839 PHE A 428 PHE A 429	1.66A	19.48	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	7btf	NSP12 (SARS-CoV-2)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.59A	19.48	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	7btf	NSP12 (SARS-CoV-2)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	7btf	NSP12 (SARS-CoV-2)	5 / 10	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.73A	19.47	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	7btf	NSP12 (SARS-CoV-2)	5 / 12	ASP A 833 GLY A 841 GLY A 839 PHE A 428 PHE A 429	1.69A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	7btf	NSP12 (SARS-CoV-2)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.62A	19.47	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.62A	19.62	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	7bv1	NSP12 (SARS-CoV-2)	5 / 10	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.77A	19.62	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.63A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.59A	19.58	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	7bv1	NSP12 (SARS-CoV-2)	5 / 12	ASP A 833 GLY A 841 GLY A 839 PHE A 428 PHE A 429	1.76A	19.58	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	7bv2	NSP12 (SARS-CoV-2)	5 / 10	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.79A	19.62	U P 18 ( 3.9A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	ASP A 833 GLY A 841 GLY A 839 PHE A 428 PHE A 429	1.65A	19.58	None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.66A	19.62	U P 18 ( 3.9A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	ASP A 833 GLY A 841 GLY A 839 PHE A 428 PHE A 429	1.69A		None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.66A		U P 18 ( 3.9A) None None None None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	7bv2	NSP12 (SARS-CoV-2)	5 / 12	ASP A 865 GLY A 839 GLY A 841 TYR A 884 PHE A 859	1.63A	19.58	U P 18 ( 3.9A) None None None None